In 2019, *** percent of the respondents aged 80 years and above experienced heart attacks in the Philippines. Additionally, *** percent aged 60 to 69 and ** to ** have also experienced heart attacks.

In 2021, there were nearly ***** deaths caused by heart disease in Quezon City in the National Capital Region of the Philippines. Meanwhile, there were only *** deaths from such disease in Pateros. The total number of deaths which caused by heart disease in the National Capital Region amounted to around ****** deaths in that same year.

In 2021, Cagayan de Oro city had the highest number of deaths by heart diseases in the Philippines' Northern Mindanao region, accounting for just over ***** out of nearly ****** total deaths across the region. On the other hand, the city of El Salvador reported only ** deaths by heart diseases in the same year.

In Philippines Ischemic Heart Disease Market, It has experienced significant growth in recent years due to the rising prevalence of cardiovascular diseases, changing lifestyle factors, and advancements in diagnostic and therapeutic technologies.

In 2021, Bulacan had the highest number of deaths by heart diseases in the Philippines' Central Luzon region, accounting for nearly ***** out of approximately ****** in this region. In comparison, Palayan City had only ** deaths in that same year.

In 2021, Cotabato had the highest number of deaths by heart diseases in the Philippines' SOCCSKSARGEN region, accounting for ***** out of nearly ***** total deaths across the region. On the other hand, the city of Tacurong reported *** deaths from heart diseases in the same year.

According to preliminary data for 2024, ischaemic heart disease was the leading cause of death in the Philippines. Deaths caused by this disease accounted for 19.2 percent of the total share of deaths in the country. This was followed by cancer, which held about 11 percent of the total registered deaths.

Philippines Chronic Heart Failure Therapeutics Market is projected to grow around USD 7.5 billion in 2025 to USD 14.6 billion by 2031, at a CAGR of 11.3%.

In 2021, Isabela had the highest number of deaths by heart diseases, accounting for roughly ***** out of roughly ***** total cases in the Philippines' Cagayan Valley region. In comparison, Batanes only reported ** deaths that year.

Philippines Heart Failure Drugs Market is projected to grow around USD 22.9 Billion by 2031, at a CAGR of 7.8% during the forecast period.

Heart Failure (HF) poses a significant clinical and economic burden globally. Due to its progressive and chronic nature, HF requires both continuous medical management and acute care related to hospitalization. This study aimed to estimate the economic burden of HF in the Philippines, covering both outpatient care and inpatient management. The study utilized a bottom-up micro-costing approach to determine the economic burden of heart failure with mildly reduced ejection fraction (HFmrEF)/heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) across all NYHA classifications using a societal perspective. Price data were gathered from clinical experts, public and private hospitals, while quantity and probability assumptions were derived from published literature, subsequently validated through clinical expert consensus. In 2022, an estimated 914,892 individuals were diagnosed with HF in the Philippines, based on a prevalence rate of 0.82%. This equates to a total economic burden of PHP 80.9B (USD 1.5B). Direct costs accounted for 90% of the total burden at PHP 72.8B (USD 1.3B). Hospital and medication expenses represented 61% of the total cost-of-illness, amounting to PHP 49.2B (USD 887.6 M). HF management poses a significant burden-of-disease for Filipinos. The annual societal costs of HF management potentially expose Filipinos to catastrophic health spending and impoverishment, especially in a system where a substantial portion of healthcare expenses are paid out-of-pocket. These findings highlight the urgent need to prioritize preventive public health interventions and enhance financial risk protection for HF patients.

In 2021, Baguio City had the highest number of deaths by heart diseases in the Philippines' Cordillera Administrative region, accounting for *** out of approximately ***** cases in this region. In comparison, Kalinga had *** reported deaths in that same year.

The total health expenditure accounted for 5.9 percent of the gross domestic product (GDP) of the Philippines in 2024. Since 2014, spending on human health has been stable, remaining between four and five percent of the GDP until 2021, when it reached 6.4 percent of the country's GDP. Health status of the aging population The Philippines was home to an estimated 113 million inhabitants in 2023. Along with the year-on-year increase in population came the need for broader healthcare services, especially for senior citizens who are at a higher risk of illnesses and diseases. In 2019, about seven percent of the aging population aged 60 years and older experienced a heart attack.  One of the leading health conditions diagnosed among the aging population was high blood pressure, arthritis, neuralgia, or rheumatism. Around 50 percent of women were diagnosed with high blood pressure, while 38.4 percent of men were diagnosed.    Health care protection With the Universal Health Care (UHC) Act enacted in 2019, more Filipinos can now have access to a government-subsidized public health insurance. The implementation of the program is under the Philippine Health Insurance Corporation (PhilHealth), alongside other related agencies. As of 2024, there were roughly 59 million registered members, the majority of whom were private employees.

Objective: The objective of this study is to systematically review the economic evaluations of dapagliflozin in the treatment of patients with heart failure (HF) and describe their general and methodological features.Methods: This systematic review followed the PRISMA guidelines. MEDLINE/PubMed, Website Of Science, Embase, The Cochrane Library, ScienceDirect, CNKI, and Wanfang databases were searched to collect relevant studies, and the retrieval time ended on 31 October 2021. Articles on the economic evaluation of dapagliflozin in the treatment of heart failure were included. Secondary studies, incomplete economic indicators, and non-English-language and non-Chinese-language studies were excluded. Standard drug treatment was selected as the comparison. Basic characteristics, methods, and main results were extracted and analyzed systematically.Result: A total of eight studies were identified, and the overall quality was accepted, which were performed in nine developed countries (Austria, United States, Korea, Japan, Singapore, Spanish, Germany, and United Kingdom) and three developing countries (the Philippines, Thailand, and China). With the exception of the Philippines, the remaining countries considered that dapagliflozin was cost effective. In the analyses of all included studies, the incremental cost-effectiveness ratios were most sensitive to the cost of dapagliflozin, cardiovascular mortality, the duration of dapagliflozin effectiveness, and the probability of HF hospitalization.Conclusion: Dapagliflozin in the treatment of patients with heart failure with reduced ejection fraction was considered cost effective. Further studies are needed to evaluate the comprehensive value of dapagliflozin on HF.

In 2021, Rizal had the highest number of deaths by heart diseases in the Philippines' CALABARZON region, accounting for nearly ***** out of approximately ****** cases in this region. On the other hand, City of Tayabas reported only *** deaths in that year.

Complete list of parts, components and items used in fabricating and using the OFM.

BackgroundDespite an unknown cause, Kawasaki disease (KD) is currently the primary leading cause of acquired heart disease in developed countries in children and has been increasing in recent years. Research efforts have explored environmental factors related to KD, but they are still unclear especially in the tropics. We aimed to describe the incidence of KD in children, assess its seasonality, and determine its association with ambient air temperature in the National Capital Region (NCR), Philippines from January 2009 to December 2019.MethodsMonthly number of KD cases from the Philippine Pediatric Society (PPS) disease registry was collected to determine the incidence of KD. A generalized linear model (GLM) with quasi-Poisson regression was utilized to assess the seasonality of KD and determine its association with ambient air temperature after adjusting for the relevant confounders.ResultsThe majority of KD cases (68.52%) occurred in children less than five years old, with incidence rates ranging from 14.98 to 23.20 cases per 100,000 population, and a male-to-female ratio of 1.43:1. Seasonal variation followed a unimodal shape with a rate ratio of 1.13 from the average, peaking in March and reaching the lowest in September. After adjusting for seasonality and long-term trend, every one-degree Celsius increase in the monthly mean temperature significantly increased the risk of developing KD by 8.28% (95% CI: 2.12%, 14.80%). Season-specific analysis revealed a positive association during the dry season (RR: 1.06, 95% CI: 1.01, 1.11), whereas no evidence of association was found during the wet season (RR: 1.10, 95% CI: 0.95, 1.27).ConclusionWe have presented the incidence of KD in the Philippines which is relatively varied from its neighboring countries. The unimodal seasonality of KD and its linear association with temperature, independent of season and secular trend, especially during dry season, may provide insights into its etiology and may support enhanced KD detection efforts in the country.

In 2021, Leyte province had the highest number of deaths by heart diseases in the Philippines' Eastern Visayas region, accounting for around ***** out of nearly ***** deaths across the region. In comparison, the city of Borongan reported *** deaths caused by heart diseases in the same year.

In 2021, Agusan del Sur had the highest number of deaths by heart diseases in the Philippines' CARAGA region, accounting for *** out of approximately ***** total deaths across the region. On the other hand, the city of Tandag recorded *** deaths caused by heart diseases in the same year.

In 2021, Maguindanao province had the highest number of deaths by heart diseases in the Philippines' Bangsamoro Autonomous Region of Muslim Mindanao, accounting for *** out of around ***** total deaths across the region. On the other hand, Tawi-Tawi city recorded only ** deaths caused by heart diseases in the same year.